Waverly Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.5M Buy
61,378
+3,240
+6% +$3.28M 0.42% 51
2025
Q4
$62.5M Buy
58,138
+7,052
+14% +$6.74M 0.51% 38
2025
Q3
$39M Buy
51,086
+7,109
+16% +$5.29M 0.39% 55
2025
Q2
$34.3M Buy
43,977
+7,174
+19% +$5.57M 0.38% 54
2025
Q1
$30.4M Buy
36,803
+4,787
+15% +$3.98M 0.37% 59
2024
Q4
$24.7M Buy
32,016
+14,676
+85% +$12.2M 0.38% 57
2024
Q3
$15.4M Buy
17,340
+36
+0.2% +$32.4K 0.28% 66
2024
Q2
$15.7M Sell
17,304
-196
-1% -$157K 0.31% 65
2024
Q1
$13.6M Buy
17,500
+5,525
+46% +$3.93M 0.32% 57
2023
Q4
$6.98M Buy
11,975
+891
+8% +$520K 0.26% 65
2023
Q3
$5.95M Buy
11,084
+3,348
+43% +$1.73M 0.26% 72
2023
Q2
$3.63M Sell
7,736
-4,991
-39% -$2.09M 0.16% 91
2023
Q1
$4.37M Buy
12,727
+10,831
+571% +$3.65M 0.23% 67
2022
Q4
$694K Buy
1,896
+205
+12% +$72.7K 0.04% 148
2022
Q3
$547K Buy
1,691
+1,037
+159% +$329K 0.04% 150
2022
Q2
$212K Buy
+654
New +$196K 0.02% 194
2015
Q4
Sell
-213
Closed -$18K 277
2015
Q3
$18K Hold
213
0.01% 291
2015
Q2
$18K Hold
213
0.01% 224
2015
Q1
$15K Hold
213
0.01% 219
2014
Q4
$15K Sell
213
-98
-32% -$6.62K 0.01% 242
2014
Q3
$20K Buy
311
+2
+0.6% +$127 0.01% 332
2014
Q2
$19K Buy
309
+35
+13% +$2.09K 0.01% 341
2014
Q1
$16K Sell
274
-209
-43% -$11.7K 0.01% 352
2013
Q4
$25K Buy
483
+67
+16% +$3.35K 0.01% 426
2013
Q3
$21K Buy
+416
New +$21.8K 0.01% 350

Other funds holding LLY

Waverly Advisors's LLY Position: Q1 2026 in Review

Waverly Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q1 2026, buying an estimated $3.28M and bringing the position to 61,378 shares worth $56.5M. The position accounts for 0.42% of the portfolio, ranked #51.

Waverly Advisors first reported a position in LLY in Q3 2013 and has held it in 25 quarters since. The position peaked at $62.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Waverly Advisors held 61,378 shares of Eli Lilly worth $56.5M as of Q1 2026.
  • Waverly Advisors bought 3,240 Eli Lilly shares in Q1 2026, an estimated $3.28M.
  • Eli Lilly made up 0.42% of Waverly Advisors's portfolio in Q1 2026, its #51 holding.
  • Waverly Advisors first reported a position in Eli Lilly in Q3 2013 and has held it in 25 quarters since.
  • Waverly Advisors's Eli Lilly position peaked at $62.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.